These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25880971)

  • 1. Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk.
    Fussner LA; Heimbach JK; Fan C; Dierkhising R; Coss E; Leise MD; Watt KD
    Liver Transpl; 2015 Jul; 21(7):889-96. PubMed ID: 25880971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients.
    Siddiqui MB; Patel S; Arshad T; Lee E; Albhaisi S; Driscoll C; Wolver S; Reichman T; Bhati C; Siddiqui MS
    Transplantation; 2019 Nov; 103(11):2323-2328. PubMed ID: 30946215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
    D'Avola D; Cuervas-Mons V; Martí J; Ortiz de Urbina J; Lladó L; Jimenez C; Otero E; Suarez F; Rodrigo JM; Gómez MA; Fraga E; Lopez P; Serrano MT; Rios A; Fábrega E; Herrero JI
    Liver Transpl; 2017 Apr; 23(4):498-509. PubMed ID: 28160394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effect of pretransplant obesity, diabetes, and cardiovascular risk factors on outcomes after liver transplantation.
    Dare AJ; Plank LD; Phillips AR; Gane EJ; Harrison B; Orr D; Jiang Y; Bartlett AS
    Liver Transpl; 2014 Mar; 20(3):281-90. PubMed ID: 24395145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation.
    Watt KD; Coss E; Pedersen RA; Dierkhising R; Heimbach JK; Charlton MR
    Liver Transpl; 2010 Aug; 16(8):990-8. PubMed ID: 20677290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels.
    Coss E; Watt KD; Pedersen R; Dierkhising R; Heimbach JK; Charlton MR
    Liver Transpl; 2011 Jan; 17(1):23-31. PubMed ID: 21254341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.
    Chhatrala R; Siddiqui MB; Stravitz RT; Driscoll C; Sanyal A; Sargeant C; Luketic V; Sharma A; Sterling R; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 May; 21(5):623-30. PubMed ID: 25762084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Predictors, and Impact on Survival of Long-term Cardiovascular Events After Liver Transplantation.
    Sastre L; García R; Gándara JG; Ruiz P; Lombardo J; Colmenero J; Navasa M; Crespo G
    Transplantation; 2020 Feb; 104(2):317-325. PubMed ID: 31335770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-factor clustering and cardiovascular disease risk in hypertensive patients.
    Weycker D; Nichols GA; O'Keeffe-Rosetti M; Edelsberg J; Khan ZM; Kaura S; Oster G
    Am J Hypertens; 2007 Jun; 20(6):599-607. PubMed ID: 17531915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.
    Idowu MO; Chhatrala R; Siddiqui MB; Driscoll C; Stravitz RT; Sanyal AJ; Bhati C; Sargeant C; Luketic VA; Sterling RK; Contos M; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 Nov; 21(11):1395-402. PubMed ID: 26228654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
    Mangus RS; Lutz AJ; Fridell JA; Kubal CA; Bush WJ; Tector AJ
    Transplantation; 2015 Sep; 99(9):1855-61. PubMed ID: 26308416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal outcomes after liver transplantation in the model for end-stage liver disease era.
    Sharma P; Welch K; Eikstadt R; Marrero JA; Fontana RJ; Lok AS
    Liver Transpl; 2009 Sep; 15(9):1142-8. PubMed ID: 19718633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health significance of four cardiovascular risk factors assessed 25 years ago in a low prevalence country.
    Faeh D; Braun J; Tarnutzer S; Bopp M
    Eur J Prev Cardiol; 2013 Feb; 20(1):151-60. PubMed ID: 22080525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function in pediatric liver transplantation: a long-term follow-up study.
    Harambat J; Ranchin B; Dubourg L; Liutkus A; Hadj-Haïssa A; Rivet C; Boillot O; Lachaux A; Cochat P
    Transplantation; 2008 Oct; 86(8):1028-34. PubMed ID: 18946339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pre-Transplant Profile of Cardiovascular Risk Factors and Its Impact on Long-Term Mortality After Liver Transplantation.
    Główczyńska R; Galas M; Witkowska A; Ołdakowska-Jedynak U; Raszeja-Wyszomirska J; Krasuski K; Milkiewicz P; Krawczyk M; Zieniewicz K; Opolski G
    Ann Transplant; 2018 Aug; 23():591-597. PubMed ID: 30127335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients.
    Rademacher S; Seehofer D; Eurich D; Schoening W; Neuhaus R; Oellinger R; Denecke T; Pascher A; Schott E; Sinn M; Neuhaus P; Pratschke J
    Liver Transpl; 2017 Nov; 23(11):1404-1414. PubMed ID: 28590598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease incidence, mortality and case fatality related to diabetes and metabolic syndrome: A community-based prospective study (Ansung-Ansan cohort 2001-12).
    Bae JC; Cho NH; Suh S; Kim JH; Hur KY; Jin SM; Lee MK
    J Diabetes; 2015 Nov; 7(6):791-9. PubMed ID: 25407754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.
    Vanwagner LB; Bhave M; Te HS; Feinglass J; Alvarez L; Rinella ME
    Hepatology; 2012 Nov; 56(5):1741-50. PubMed ID: 22611040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.